Perceptive Advisors’s Verona Pharma VRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$521M Sell
5,507,591
-1,055,749
2025
Q1
$417M Buy
6,563,340
+171,234
2024
Q4
$297M Buy
6,392,106
+76,173
2024
Q3
$182M Buy
6,315,933
+3,882,208
2024
Q2
$35.2M Sell
2,433,725
-1,327,851
2024
Q1
$60.5M Sell
3,761,576
-104,638
2023
Q4
$76.9M Sell
3,866,214
-140,983
2023
Q3
$65.3M Sell
4,007,197
-389,919
2023
Q2
$93M Buy
4,397,116
+1,663,326
2023
Q1
$54.9M Sell
2,733,790
-2,146,929
2022
Q4
$128M Sell
4,880,719
-166,545
2022
Q3
$51.6M Buy
5,047,264
+2,132,118
2022
Q2
$12.2M Sell
2,915,146
-129,157
2022
Q1
$15.2M Buy
3,044,303
+176,793
2021
Q4
$19.3M Sell
2,867,510
-21,379
2021
Q3
$15.8M Hold
2,888,889
2021
Q2
$18.9M Hold
2,888,889
2021
Q1
$24.2M Hold
2,888,889
2020
Q4
$20.2M Hold
2,888,889
2020
Q3
$18M Buy
+2,888,889
2018
Q3
Sell
-22,327
2018
Q2
$307K Sell
22,327
-33,841
2018
Q1
$1.12M Sell
56,168
-143,832
2017
Q4
$2.38M Hold
200,000
2017
Q3
$3.07M Hold
200,000
2017
Q2
$2.33M Buy
+200,000